Kalaris Therapeutics Inc. (KLRS) Live Share Price, Invest From India

Kalaris Therapeutics Inc. Stock Performance

as on July 17, 2026 at 2:15 pm IST

Day's Low
Day's High
$4.42
Day's Price Range
$4.77
$4.61
4.12%
Downside
3.47%
Upside
52 Week's Low
52 Week's High
$2.14
52-Week Price Range
$11.88
$4.61
53.58%
Downside
157.70%
Upside

Kalaris Therapeutics Inc. share price movements today

Previous Close: $4.82
Open: $4.77
Volume: 271.5K
Day's Low - High: $4.42 - $4.77
52 Week Low - High: $2.14 - $11.88

Kalaris Therapeutics Inc. Historical Returns

1 Month Return: + 1.32 %
3 Month Return: -27.06 %
1 Year Return: + 90.5 %
3 Year Return: 0 %
5 Year Return: 0 %

Kalaris Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Kalaris Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$114.7M

EPS (TTM)

-2.0263

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-66.60%

Kalaris Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kalaris Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Kalaris Therapeutics Inc.	NA	$114.7M	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$39.2B	501.07%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$122.9B	140.28%	28.76	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$71.2B	16.41%	16.59	29.65%	0.54%

Stock Returns calculator for Kalaris Therapeutics Inc. Stock including INR - Dollar returns

The Kalaris Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Kalaris Therapeutics Inc. investment value today

Current value as on today

₹2,13,158

Returns

₹1,13,158

(+113.16%)

Returns from Kalaris Therapeutics Inc. Stock

₹90,496 (+90.5%)

Dollar Impact

₹22,662 (+22.66%)

Indian Investors' Interest in Kalaris Therapeutics Inc. Stock

Search interest for Kalaris Therapeutics Inc. Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 17, 2026 to July 17, 2026

Change:33% versus previous 30 day period

Kalaris Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	0	0
Operating Income	-3	-2	-4	-37	-19	-10	-12	-12	-10	-11
EBITDA	-3	-3	-5	-37	-18	-8	-11	-11	-9	-10
Interest Expense	0	0	0	0	1	1	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	0	0
Income Before Tax	-3	-3	-5	-38	-18	-10	-11	-11	-9	-10
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-3	-3	-5	-38	-18	-10	-11	-11	-9	-10
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Kalaris Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	1	0	-	-	-	-
Gross Profit	-	-	-	-	-	0
Operating Income	-3	-26	-14	-13	-55	-46
EBITDA	-2	-23	-15	-14	-58	-41
Interest Expense	-	-	0	0	2	1
Depreciation	-	-	-	-	-	0
Income Before Tax	-2	-23	-15	-14	-58	-43
Income Tax Expense	-	-	-	-	-	-
Net Income	-2	-23	-15	-14	-58	-43
Net Profit Margin	-214.10%	-14447.88%	0.00%	0.00%	0.00%	0.00%

Kalaris Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-3	-5	-38	-22	-10	-11	-11	-9	-10
Operating Cash Flow	-4	-3	-4	-7	-7	-14	-11	-9	-13
Investing Cash Flow	-	-	-	-	-	-	-34	14	-50
Financing Cash Flow	6	4	0	7	107	2	-	50	0
Change in Cash	2	1	12	0	99	-12	-46	55	-63

Kalaris Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-23	-69	-171	-15	-14	-58	-43
Operating Cash Flow	-20	-60	-106	-9	-14	-67	-42
Investing Cash Flow	-64	-169	185	-	-	95	-19
Financing Cash Flow	120	291	0	12	14	0	159
Change in Cash	36	61	79	3	0	28	-20

Global Institutional Holdings in Kalaris Therapeutics Inc.

Funds	Holdings
RTW INVESTMENTS, LLC	5.46%
Geode Capital Management, LLC	0.37%
Paradigm Biocapital Advisors LP	2.94%
Siren, L.L.C.	1.83%
Vanguard Group Inc	1.23%

See all

Insights on Kalaris Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 358.8% return, outperforming this stock by 268.3%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 573.4% return, outperforming this stock by 667.9%
NEGATIVE IMPACT
Price Dip
In the last 6 months, KLRS stock has moved down by -52.7%

About Kalaris Therapeutics Inc.

Kalaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for prevalent retinal diseases. It develops TH103, a clinical-stage anti-vascular endothelial growth factor (VEGF) drug for the treatment of neovascular age-related macular degeneration (nAMD), which is in Phase 1b/2, as well as for the treatment of other exudative and neovascular retinal diseases. Kalaris Therapeutics, Inc. was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. The company was founded in 2019 and is headquartered in Berkeley Heights, New Jersey.

Organisation	Kalaris Therapeutics Inc.
Headquarters	400 Connell Drive, Berkeley Heights, NJ, United States, 07922
Industry	Biotechnology
CEO	Mr. Andrew Oxtoby
E-voting on shares	Click here to vote

Key Management of Kalaris Therapeutics Inc.

Name	Title
Dr. Jill E. Porter Ph.D.	Senior Vice President of CMC
Mr. Andrew Oxtoby	President, CEO & Director
Dr. Srinivas Akkaraju M.D., Ph.D.	Director & Co-Founder
Dr. Michael Philip Dybbs Ph.D.	Co-Founder & Director
Dr. Napoleone Ferrara M.D.	Independent Director & Co-Founder
Mr. Brett R. Hagen	Chief Accounting Officer and Principal Accounting & Financial Officer
Dr. Matthew Feinsod M.D.	Chief Medical Officer
Ms. Kristine Curtiss	Senior Vice President of Clinical

FAQs

What is Kalaris Therapeutics Inc. share price today?

Kalaris Therapeutics Inc. share price today is $4.61 as on July 17, 2026 at 8:45 am IST at the close of the market. Kalaris Therapeutics Inc. share today touched a day high of $4.77 and a low of $4.42.

What is the 52 week high and 52 week low for Kalaris Therapeutics Inc. share?

Kalaris Therapeutics Inc. share touched a 52 week high of $11.88 on December 18, 2025 and a 52 week low of $2.14 on August 14, 2025. Kalaris Therapeutics Inc. stock price today i.e. July 17, 2026 at 8:45 am IST is closed at $4.61,which is 61.20% down from its 52 week high and 115.42% up from its 52 week low.

What is Kalaris Therapeutics Inc.'s market capitalisation today?

Kalaris Therapeutics Inc. market capitalisation is $0.00T as on July 17, 2026 at 8:45 am IST.

How to invest in Kalaris Therapeutics Inc. Stock (KLRS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Kalaris Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kalaris Therapeutics Inc. Shares that will get you 0.3254 shares as per Kalaris Therapeutics Inc. share price of $4.61 per share as on July 17, 2026 at 8:45 am IST.

What is the minimum amount required to buy Kalaris Therapeutics Inc. Stock (KLRS) from India?

Indian investors can start investing in Kalaris Therapeutics Inc. (KLRS) shares with as little as ₹96.27 or $1 (as of July 17, 2026 at 6:48 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹962.70 in Kalaris Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on July 17, 2026 at 6:48 pm IST). Based on Kalaris Therapeutics Inc. share’s latest price of $4.61 as on July 17, 2026 at 8:45 am IST, you will get 2.1692 shares of Kalaris Therapeutics Inc.. Learn more about fractional shares .